Panel Discussion: De Risking De Novo & Computational Protein Design & Engineering to Build Repeatable Decision Grade Platforms for Faster Pipeline Progression

9:30 am - Wednesday 11th November 2026

  • Where has computational design actually moved the needle, and how are you proving it internally to speed up drug pipelines?
  • How to control for data quality and biological reality in ML-driven design loops? And what specific changes have you made to your data generation strategy to make it truly usable for training models?
  • How are you deciding what to prioritize today across de novo design, optimization workflows, and engineering, given they sit at different points in the hype cycle?

Speakers:

Director, Protein Design & Optimization
Tectonic Therapeutic
Director, Antibody Discovery, Protein Engineering & Development
Crossbow Therapeutics
Chief Technology Officer
AI Proteins